Interpretation of the Newly Released European Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries：Improving the Ability of Hierarchical Diagnosis and Treatment，and Strengthening the Joint Management of General Practitioners and Specialist Physicians

doi:10.12114/j.issn.1007-9572.2020.00.632

Abstract

Abstract: Ischaemia with non-obstructive coronary arteries（INOCA）refers to a disease with suspected ischemic symptoms，while no obstructive coronary artery stenosis（stenosis degree ≥50%）is found by coronary angiography.The disease is prevalent but individuals with INOCA are significantly undertreated.Recently，an EAPCI expert consensus document was released on ischaemia with non-obstructive coronary arteries in collaboration with European society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group.We interpreted the consensus document from the aspects of INOCA endotypes，epidemiology，risk factors，pathophysiology mechanism，clinical features，prognostic significance，noninvasive and invasive diagnostic methods，and patient management and medication，in order to raise awareness of clinicians for INOCA，prompt them to put a high value on INOCA endotypes and take tailored treatment，with the ultimate goals of improving angina symptoms and prognosis of patients with INOCA，and reducing medical cost.

Key words: Coronary artery disease, Microvascular angina, Coronary vasospasm, Myocardial ischemia, Angina pectoris, Expert consensus, Unscramble

摘要：

非阻塞性冠状动脉缺血疾病（INOCA）是指具有可疑缺血相关症状，但经冠状动脉造影检查没有发现阻塞性冠状动脉狭窄（狭窄程度≥50%）的疾病。该疾病患者人群广泛而治疗不足。近日，欧洲经皮心血管介入学会（EAPCI）与欧洲心脏病学会（ESC）冠状动脉病理生理学和微循环工作组联合发布了《欧洲非阻塞性冠状动脉缺血疾病专家共识》。本文结合欧洲专家共识对INOCA的亚型、患病率、危险因素、病理生理学机制、临床特征、预后意义、无创及侵入性诊断方法、患者管理和药物治疗等内容进行解读，以期提高临床医生对这类患者的认识，使其重视对疾病亚型的分类，采取个体化的治疗策略，改善患者症状及预后，降低医疗消耗。

关键词: 冠状动脉疾病, 微血管性心绞痛, 冠状血管痉挛, 心肌缺血, 心绞痛, 专家共识, 解读

HUANG Baotao,CHEN Mao. Interpretation of the Newly Released European Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries：Improving the Ability of Hierarchical Diagnosis and Treatment，and Strengthening the Joint Management of General Practitioners and Specialist Physicians　[J]. Chinese General Practice, 2021, 24(2): 125-131. DOI: 10.12114/j.issn.1007-9572.2020.00.632.
黄宝涛,陈茂. 《2020年欧洲非阻塞性冠状动脉缺血疾病专家共识》解读——提高分级诊疗能力，加强全-专联合管理[J]. 中国全科医学, 2021, 24(2): 125-131. DOI: 10.12114/j.issn.1007-9572.2020.00.632.

References

［1］GBD MORTALITY AND CAUSES OF DEATH COLLABORATORS.Global，regional，and national life expectancy，all-cause mortality，and cause-specific mortality for 249 causes of death，1980-2015：a systematic analysis for the Global Burden of Disease Study 2015［J］．Lancet（London，England），2016，388（10053）：1459-1544．DOI：10.1016/S0140-6736（16）31012-1.
［2］REEH J，THERMING C B，HEITMANN M，et al．Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina［J］．Eur Heart J，2019，40（18）：1426-1435．DOI：10.1093/eurheartj/ehy806.
［3］KUNADIAN V，CHIEFFO A，CAMICI P G，et al．An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group［J］．Eur Heart J，2020：ehaa503．DOI：10.1093/eurheartj/ehaa503.
［4］FORD T J，YII E，SIDIK N，et al．Ischemia and No obstructive coronary artery disease：prevalence and correlates of coronary vasomotion disorders［J］．Circ Cardiovasc Interv，2019，12（12）：e008126．DOI：10.1161/CIRCINTERVENTIONS.119.008126.
［5］PATEL M R，PETERSON E D，DAI D，et al．Low diagnostic yield of elective coronary angiography［J］．N Engl J Med，2010，362（10）：886-895．DOI：10.1056/NEJMoa0907272.
［6］JESPERSEN L，HVELPLUND A，ABILDSTRØM S Z，et al．Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events［J］．Eur Heart J，2012，33（6）：734-744．DOI：10.1093/eurheartj/ehr331.
［7］WESSEL T R，ARANT C B，MCGORRAY S P，et al．Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia：results from the NHLBI Women's Ischemia Syndrome Evaluation（WISE）［J］．Clin Cardiol，2007，30（2）：69-74．DOI：10.1002/clc.19.
［8］BELTRAME J F，SASAYAMA S，MASERI A.Racial heterogeneity in coronary artery vasomotor reactivity：differences between Japanese and Caucasian patients［J］．J Am Coll Cardiol，1999，33（6）：1442-1452．DOI：10.1016/s0735-1097（99）00073-x.
［9］SUEDA S，KOHNO H，FUKUDA H，et al．Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine［J］．Angiology，2004，55（4）：403-411．DOI：10.1177/000331970405500407.
［10］HUNG M Y，HSU K H，HUNG M J，et al．Interactions among gender，age，hypertension and C-reactive protein in coronary vasospasm［J］．Eur J Clin Invest，2010，40（12）：1094-1103．DOI：10.1111/j.1365-2362.2010.02360.x.
［11］BERTRAND M E，LABLANCHE J M，TILMANT P Y，et al．Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography［J］．Circulation，1982，65（7）：1299-1306．DOI：10.1161/01.cir.65.7.1299.
［12］HUNG M J，CHERNG W J，CHENG C W，et al．Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease［J］．Am J Cardiol，2006，97（10）：1429-1434．DOI：10.1016/j.amjcard.2005.12.035.
［13］MEJÍA-RENTERÍA H，VAN DER HOEVEN N，VAN DE HOEF T P，et al．Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests［J］．Int J Cardiovasc Imaging，2017，33（7）：1041-1059．DOI：10.1007/s10554-017-1136-9.
［14］BAIREY MERZ C N，PEPINE C J，WALSH M N，et al．Ischemia and no obstructive coronary artery disease（INOCA）：Developing evidence-based therapies and research agenda for the next decade［J］．Circulation，2017，135（11）：1075-1092．DOI：10.1161/CIRCULATIONAHA.116.024534.
［15］BRAININ P，FRESTAD D，PRESCOTT E.The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease：A systematic review and meta-analysis［J］．Int J Cardiol，2018，254：1-9．DOI：10.1016/j.ijcard.2017.10.052.
［16］KNUUTI J，WIJNS W，SARASTE A，et al．2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes［J］．Eur Heart J，2020，41（3）：407-477．DOI：10.1093/eurheartj/ehz425.
［17］SHEIKH A R，ZEITZ C J，RAJENDRAN S，et al．Clinical and coronary haemodynamic determinants of recurrent chest pain in patients without obstructive coronary artery disease-A pilot study［J］．Int J Cardiol，2018，267：16-21．DOI：10.1016/j.ijcard.2018.04.077.
［18］WILLIAMS R P，DE WAARD G A，DE SILVA K，et al．Doppler versus thermodilution-derived coronary microvascular resistance to predict coronary microvascular dysfunction in patients with acute myocardial infarction or stable angina pectoris［J］．Am J Cardiol，2018，121（1）：1-8．DOI：10.1016/j.amjcard.2017.09.012.
［19］NEUMANN F J，SOUSA-UVA M，AHLSSON A，et al．2018 ESC/EACTS Guidelines on myocardial revascularization［J］．Eur Heart J，2019，40（2）：87-165．DOI：10.1093/eurheartj/ehy394.
［20］中华医学会心血管病学分会基础研究学组，中华医学会心血管病学分会介入心脏病学组，中华医学会心血管病学分会女性心脏健康学组，等．冠状动脉微血管疾病诊断和治疗的中国专家共识［J］．中国循环杂志，2017，32（5）：421-430．DOI：10.3969/j.issn.1000-3614.2017.05.003.
［21］中华医学会心血管病学分会介入心脏病学组，中华医学会心血管病学分会动脉粥样硬化与冠心病学组，中国医师协会心血管内科医师分会血栓防治专业委员会，等．稳定性冠心病诊断与治疗指南［J］ .中华心血管病杂志，2018，46（9）：680-694．DOI：10.3760/cma.j.issn.0253-3758.2018.09.004.
［22］FORD T J，STANLEY B，GOOD R，et al．Stratified medical therapy using invasive coronary function testing in angina：The CorMicA Trial［J］．J Am Coll Cardiol，2018，72（23 Pt A）：2841-2855．DOI：10.1016/j.jacc.2018.09.006.
［23］MEHTA P K，SHARMA S，MINISSIAN M，et al．Ranolazine reduces angina in women with ischemic heart disease：Results of an open-label，multicenter trial［J］．J Womens Health（Larchmt），2019，28（5）：573-582．DOI：10.1089/jwh.2018.7019.
［24］KRONHAUS K D，LAWSON W E.71 enhanced external counterpulsation improves microvascular angina in coronary artery disease patients［J］．J Invest Med，2005，53（2）：S399．DOI：10.2310/6650.2005.00205.70.

[1]	JIA Gaopeng, CHEN Qiuyu. Construction and Validation of a Risk Prediction Model for Recurrent Angina after Percutaneous Coronary Intervention in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction: Based on CYP2C19-related Genetic Testing [J]. Chinese General Practice, 2025, 28(30): 3779-3786.
[2]	National Clinical Research Center for Infectious Diseases Jiangxi Branch, Jiangxi Provincial Key Laboratory of Tuberculosis. Expert Consensus on the Treatment of Pulmonary Tuberculosis Complicated with Chronic Hepatitis B Virus Infection [J]. Chinese General Practice, 2025, 28(24): 2961-2967.
[3]	Chinese Geriatrics Society, General Practice Branch of Zhejiang Medical Association, the Expert Collaboration Group on Medically Unspecified Disease in General Practice. Expert Consensus on the Diagnosis, Treatment, and Management of Emaciation (2025) [J]. Chinese General Practice, 2025, 28(21): 2577-2594.
[4]	YIN Yingying, ZHAO Kuan, WANG Cailian, TANG Lichen, HE Hongbo, LIU Xiangxin, PAN Yu, YANG Hailong, YANG Yang, ZHOU Bo, XIE Ke, LIN Zheng, YU Linzhen, LUO Yanli, LU Zheng, WANG Xiaoping, REN Tao, ZOU Shaohong, WEI Jing, FENG Wei, YUAN Yonggui. Chinese Expert Consensus on Clinical Management of the Psychosomatic Symptoms in Patients with Cancer [J]. Chinese General Practice, 2025, 28(15): 1809-1822.
[5]	CHAI Yiyi, YE Qingfang, LIN Ping, LI Ling. Current Status and Influencing Factors of Motoric Cognitive Risk in Patients with Coronary Artery Disease in Frigid Zone [J]. Chinese General Practice, 2025, 28(14): 1730-1736.
[6]	Gynecological Oncology Group of the Oncology Department of Capital Medical University. Expert Consensus on Management of Common Gynecological Malignancies Combining General Practice and Specialist [J]. Chinese General Practice, 2025, 28(08): 911-922.
[7]	WANG Rui, OUYANG Lina, WU Qian, NIU Yuanyuan, LI Guilan, ZHU Li. The Value of CT-FFR in Predicting Major Adverse Cardiovascular Events in Patients with Obstructive Coronary Artery Disease [J]. Chinese General Practice, 2025, 28(06): 713-719.
[8]	ZHANG Wenjie, LI Jun, CHEN Hengwen, TAN Yuqing, XIE Zicong, WU Ji, MENG Chao, LI Zhaoling, ZHANG Lesong. Collection and Determination of Clinical Problems and Outcome Indicators of Expert Consensus on Clinical Application of Ethnic Medicine in the Treatment of Palpitation (Arrhythmia-premature Ventricular Complexes) [J]. Chinese General Practice, 2025, 28(04): 407-412.
[9]	WU Xia, ZHANG Yiyun, YAO Chengzhi, ZHAO Xiangling, XIONG Wenjing, RANG Weiqing. Trend and Prediction of Changes in the Disease Burden of Diet-related Ischemic Heart Disease in China, 1990-2021 [J]. Chinese General Practice, 2025, 28(03): 305-312.
[10]	Tsinghua University Vanke School of Public Health, Peking University School of Public Health, Chinese Association of General Practitioners of Chinese Medical Doctor Association. Chinese Expert Consensus on Artificial Intelligence General Practitioner (AIGP) [J]. Chinese General Practice, 2025, 28(02): 135-142.
[11]	Public Health Security and Health Professional Committee of the Public Safety Science and Technology Society, General Practitioner Branch of Chinese Medical Doctor Association. Expert Consensus on Primary Health Governance 2024 [J]. Chinese General Practice, 2025, 28(01): 13-19.
[12]	ZHANG Qiongdan, MAO Zhuoni, HUANG Dan, FANG Li. Correlation of Nucleolin with the Stability and Severity of Coronary Plaque in Acute Coronary Syndrome [J]. Chinese General Practice, 2024, 27(36): 4561-4567.
[13]	JIA Jia, LIU Jiahui, JI Wenjun, ZHENG Bo, WANG Xingang, FAN Fangfang, LI Yin, ZHANG Long, ZHANG Yan. Analysis of Influencing Factors of Plasma Proprotein Convertase Subtilisin/Kexin Type 9 in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2024, 27(36): 4568-4574.
[14]	LU Na, LIU Huaqing, JI Yunxin, GUO Rongjuan, HE Danjun, JIAO Zhian, LIN Yuerui, TIAN Feng, ZHANG Guiqing, XU Zhi, AN Ganghui, ZHANG Yan, YUAN Yonggui. Chinese Expert Consensus on Clinical Diagnosis and Treatment of Test Anxiety Disorder [J]. Chinese General Practice, 2024, 27(34): 4225-4233.
[15]	Diabetes and Microcirculation Professional Committee of Chinese Society of Microcirculation, Primary Endocrine and Metabolic Diseases Group of the Chinese Society of Endocrinology. Expert Consensus on Screening and Prevention of Diabetic Microvascular Disease for Primary Care (2024) [J]. Chinese General Practice, 2024, 27(32): 3969-3986.